Completed PHASE4 INTERVENTIONAL 2-arm NCT01087567

INSPIRE Diabetes Study: Basal Bolus Insulin as Primary Treatment of Type 2 Diabetes (INSPIRE)

A Pilot Study of Intensive Insulin Regimen as a Primary Treatment of New Onset of Type 2 DM

Sponsor: Ohio University

Interventions Intensive insulin Routine Care

Updated 6 times since 2017 Last updated: Apr 16, 2014 Started: Jul 31, 2010 Primary completion: Jan 31, 2014 Completion: Jan 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Type 2 Diabetes, this trial is completed. The trial is conducted by Ohio University and has accumulated 6 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jul 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ohio University
Western University of Health Sciences

Data source: Ohio University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Athens, United States